341.14
Bio Rad Laboratories Inc stock is traded at $341.14, with a volume of 131.55K.
It is down -1.27% in the last 24 hours and down -0.87% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$345.41
Open:
$345.7
24h Volume:
131.55K
Relative Volume:
0.80
Market Cap:
$9.67B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-12.48
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
-5.51%
1M Performance:
-0.87%
6M Performance:
+7.00%
1Y Performance:
+4.87%
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BIO
Bio Rad Laboratories Inc
|
341.39 | 9.67B | 2.58B | -778.69M | 223.75M | -27.33 |
![]()
ABT
Abbott Laboratories
|
128.91 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
105.34 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
![]()
SYK
Stryker Corp
|
391.43 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
89.80 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
![]()
EW
Edwards Lifesciences Corp
|
71.06 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
Jun-03-24 | Resumed | Jefferies | Hold |
Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
Dec-07-23 | Initiated | UBS | Buy |
Jun-16-23 | Initiated | Wells Fargo | Overweight |
Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
Aug-25-22 | Initiated | Credit Suisse | Outperform |
Jan-28-22 | Reiterated | Citigroup | Buy |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jan-07-20 | Initiated | Citigroup | Buy |
Oct-17-18 | Initiated | Goldman | Buy |
Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
Feb-16-18 | Downgrade | CL King | Buy → Neutral |
Jul-13-17 | Initiated | Wells Fargo | Outperform |
Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
Jan-18-17 | Initiated | Deutsche Bank | Hold |
Oct-13-16 | Initiated | CL King | Buy |
May-06-15 | Reiterated | Jefferies | Buy |
Dec-18-09 | Initiated | Maxim Group | Buy |
Nov-06-09 | Initiated | Jefferies & Co | Buy |
Jul-17-09 | Initiated | Soleil | Buy |
Sep-26-07 | Initiated | Banc of America Sec | Buy |
Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Cell Processing Instrument Market Competitive Dynamics: - openPR
KBC Group NV Sells 814 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
DAVENPORT & Co LLC Acquires 27,780 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Biopharmaceutical Bioseparation Systems Global Report 2025: Market to Benefit from Rising Demand for Monoclonal Antibodies, Forecast to Hit $32.6 Billion by 2030 - Yahoo Finance
Bio-Rad Launches Dye Label Kits for Antibody Conjugation - Contract Pharma
Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline - Yahoo Finance
Lab-on-Chip Application Market Statistics, Competitive - openPR
Blood Market to Grow by USD 2.60 Billion (2024-2028) with Rising Number of Hospitals & Blood Banks Boosting the Market, Report on How AI is Redefining Market LandscapeTechnavio - Yahoo Finance
Bio-Rad Laboratories (BIO) to Release Quarterly Earnings on Thursday - Defense World
Bio-Rad Laboratories, Inc. (NYSE:BIO) Sees Significant Increase in Short Interest - MarketBeat
Clinical Microbiology Market Generated Opportunities, Future - openPR
Janney Montgomery Scott LLC Sells 130 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Has BioRad Laboratories (BIO) Outpaced Other Medical Stocks This Year? - MSN
RBC Trims Price Target on Bio-Rad Laboratories to $477 From $481, Keeps Outperform Rating - Marketscreener.com
Pacer Advisors Inc. Sells 30 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Robeco Institutional Asset Management B.V. Sells 2,239 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
10,000 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Purchased by Sivik Global Healthcare LLC - MarketBeat
Protein Chip Market is Projected to Growing at a CAGR of 7.45% From - openPR
Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 1-Year HighTime to Buy? - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Bio-Rad launches TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits for antibody conjugation to StarBright Dyes - MSN
SG Americas Securities LLC Has $1.06 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
High Throughput Screening (HTS) Market to Grow by USD 19.9 Billion (2024-2028), Boosted by Rising R&D Investments, with AI Redefining Market LandscapeTechnavio - The Malaysian Reserve
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Fifth Third Bancorp - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Nisa Investment Advisors LLC - Defense World
Brokerages Set Bio-Rad Laboratories, Inc. (NYSE:BIO) Price Target at $394.20 - Defense World
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Impacting Market TrendsTechnavio - The Malaysian Reserve
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Driving Market TransformationTechnavio - The Malaysian Reserve
Carrier Screening Market 2024: Future Industry Scope, Growth - openPR
Bio-Rad extends range of Vericheck ddPCR Empty-Full Capsid Kits to optimize AAV vector characterization - SelectScience
[Latest] Global Single Cell Multiomics Market Size/Share Worth USD 18.90 Billion by 2033 at a 19.58% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
Laboratory Supplies Market Growth in Future Scope 2025-2032 | - openPR
Next Generation Sequencing (NGS) Market is Projected to Reach - openPR
Molecular Diagnostics Market reached 35.7 Billion by 2031, - openPR
Bio-Rad: Uncertainties And Conservatism Continue To Hold Stock Back From Its Full Potential - Seeking Alpha
Animal Health Diagnostics Market to grow by USD 2.1 Billion (2025-2029), driven by rising pet humanization, report on how AI is redefining market landscapeTechnavio - The Malaysian Reserve
Retirement Stock Portfolio: 10 Healthcare Stocks to Buy - Insider Monkey
Bio-Rad Laboratories, Inc. (BIO): Is This Healthcare Stock A Good Buy? - Insider Monkey
Bio-Rad Launches TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits for Antibody Conjugation to StarBright Dyes - The Scientist
Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits To Optimize AAV Vector Characterization - Technology Networks
S&P 500 Futures Steady in Premarket Trading; Stevanato Group, Bio-Rad Labs A Lead - Barron's
Crossmark Global Holdings Inc. Decreases Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Biomarkers Market Intelligence Report: Potential Growth - openPR
Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025 - Business Wire
Strong week for Bio-Rad Laboratories (NYSE:BIO) shareholders doesn't alleviate pain of three-year loss - Simply Wall St
Protein A Resin Market Size and Growth Analysis: Rapid Expansion - openPR
Label-free Array Systems Business Research Report 2024: Global Market to Reach $2.4 Billion by 2030 - GlobeNewswire Inc.
UMB Bank n.a. Buys 32 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):